ストックスクリーナーアプリを入手
42.60
0.33%
0.14
アフターアワーズ：
42.60
前日終値:
$42.46
開ける：
$42.4
24時間の取引高:
866.45K
Relative Volume:
0.61
時価総額：
$2.61B
収益：
$362.27M
当期純損益:
$-85.19M
株価収益率:
-29.38
EPS:
-1.45
ネットキャッシュフロー:
$-68.71M
1週間 パフォーマンス:
+2.28%
1か月 パフォーマンス:
+28.90%
6か月 パフォーマンス:
+18.37%
1年 パフォーマンス:
-18.44%
1日の値動き範囲:
$41.78
$43.34
1週間の範囲:
$41.30
$45.76
52週間の値動き範囲:
$23.30
$54.74
Twist Bioscience Corp Stock (TWST) Company Profile
名前
Twist Bioscience Corp
セクター
電話
800-719-0671
住所
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
TWST を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
42.60 | 2.60B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
623.91 | 235.43B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.75 | 167.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
694.75 | 55.72B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
241.04 | 40.77B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
135.95 | 38.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-04 | 開始されました | Stephens | Overweight |
| 2024-12-13 | 開始されました | Wolfe Research | Outperform |
| 2024-06-04 | 開始されました | Guggenheim | Buy |
| 2024-01-17 | アップグレード | Goldman | Neutral → Buy |
| 2023-09-27 | 開始されました | Berenberg | Buy |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2023-01-03 | アップグレード | Evercore ISI | In-line → Outperform |
| 2022-03-02 | 再開されました | Cowen | Outperform |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-29 | 開始されました | William Blair | Outperform |
| 2021-06-04 | 開始されました | Goldman | Neutral |
| 2021-04-12 | 開始されました | Piper Sandler | Overweight |
| 2021-02-05 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2020-10-20 | 開始されました | SVB Leerink | Mkt Perform |
| 2019-05-31 | 開始されました | Evercore ISI | Outperform |
| 2018-11-26 | 開始されました | JP Morgan | Neutral |
すべてを表示
Twist Bioscience Corp (TWST) 最新ニュース
cathie wood’s ARK stock trades: bullish and kodiak ai bought, kratos defense and twist bioscience sold - Investing.com South Africa
Cathie Wood Dumps Biotech Stocks, Loads Up on AI and Self-Driving Companies - CoinCentral
Cathie Wood’s ARK sells Twist Bioscience stock, buys Tempus AI and WeRide - Investing.com
Guggenheim Raises Price Target for Twist Bioscience (TWST) | TWS - GuruFocus
Will Twist Bioscience (TWST) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Twist Bioscience (TWST) Projected to Post Earnings on Monday - MarketBeat
Laponis, Twist Bioscience CFO, sells $120k in shares By Investing.com - Investing.com Nigeria
Laponis, Twist Bioscience CFO, sells $120k in shares - Investing.com
Insider Sell: Adam Laponis Sells 3,000 Shares of Twist Bioscience Corp (TWST) - GuruFocus
Finn, Twist Bioscience COO, sells $931k in TWST stock - Investing.com
Finn, Twist Bioscience COO, sells $931k in TWST stock By Investing.com - Investing.com Canada
Twist Bioscience president Finn sells $140,406 in stock - MSN
Twist Bioscience Corporation (TWST): Investor Outlook Reveals 16.9% Revenue Growth and Bullish Analyst Ratings - DirectorsTalk Interviews
Twist Bioscience stock jumps on early revenue beat as TWST investors eye JPM talk and Feb. 2 results - TechStock²
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue - Chartmill
Twist Bioscience (TWST) Valuation Check After TD Cowen Buy Rating And Raised Outlook - Yahoo! Finance Canada
Twist Bioscience Corporation $TWST Shares Acquired by Peregrine Capital Management LLC - MarketBeat
Analyst Brendan Smith Maintains "Buy" on Twist Bioscience (TWST), Raises Price Target | TWST Stock News - GuruFocus
Twist Bioscience Corp ($TWST) CEO and COB 2025 Pay Revealed - Quiver Quantitative
Form ARS Twist Bioscience Corp For: Sep 30 - StreetInsider
Twist Bioscience (NASDAQ:TWST) Trading 7.4% HigherShould You Buy? - MarketBeat
Twist Bioscience Corporation (TWST) Stock Analysis: Unpacking a 10.29% Potential Upside in the Diagnostics & Research Sector - DirectorsTalk Interviews
Cathie Wood’s ARK buys Beam and Twist Bioscience stocks, sells Roku - Investing.com India
Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST) - Insider Monkey
Twist Bioscience Corporation (TWST) Stock Analysis: Unveiling a 9.21% Potential Upside in Synthetic DNA Innovation - DirectorsTalk Interviews
Cathie Wood’s ARK makes strategic stock moves, buys Intellia and sells Roku - Investing.com
Twist Bioscience2025 Funding Rounds & List of Investors - Tracxn
Twist Bioscience Corporation (NASDAQ:TWST) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Insider Selling: Twist Bioscience (NASDAQ:TWST) CEO Sells 1,605 Shares of Stock - MarketBeat
Twist Bioscience (NASDAQ:TWST) Stock Price Down 4.1%Time to Sell? - MarketBeat
New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST) - Finviz
Twist Bioscience (TWST) Stock News Today: Forecasts, Analyst Targets, and Key Catalysts (Dec. 22, 2025) - ts2.tech
What valuation multiples suggest for Twist Bioscience Corporation stock2025 Price Targets & Low Risk High Reward Trade Ideas - Улправда
Will Twist Bioscience Corporation (0ME) stock remain on Wall Street radarTrade Ideas & Verified Swing Trading Watchlist - Улправда
Is Twist Bioscience Corporation (0ME) stock a contrarian opportunityPortfolio Growth Summary & Weekly Chart Analysis and Guides - DonanımHaber
Published on: 2025-12-18 20:43:14 - Улправда
Twist Bioscience (TWST): Evaluating Valuation After New Research‑Grade Plasmid DNA Preps Launch - simplywall.st
Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference - Business Wire
Squarepoint Ops LLC Raises Stock Position in Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience (NASDAQ:TWST) Trading Up 6.4%Should You Buy? - MarketBeat
Twist Bioscience (TWST) Stock News Today: Latest Catalysts, Analyst Forecasts, and 2026 Outlook (Dec. 17, 2025) - ts2.tech
Twist Bioscience Corporation (TWST) Stock Analysis: Exploring a Potential 15% Upside for Forward-Thinking Investors - DirectorsTalk Interviews
Aptamer Group Signs First Licensing Deal With Twist Bioscience - DirectorsTalk Interviews
Aptamer Group PLCLicensing agreement with Twist Bioscience - Research Tree
Aptamer Group signs licensing deal with Twist Bioscience for NGS market - Investing.com Canada
Barclays Raises Price Target for Twist Bioscience (TWST) to $39 - GuruFocus
Twist Bioscience Corp (TWST) 財務データ
収益
当期純利益
現金流量
EPS
1.40%
0.21%
大文字化:
|
ボリューム (24 時間):